{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:34:40Z","timestamp":1777962880358,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.17269\/cjph.105.4143","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T14:51:51Z","timestamp":1477493511000},"page":"e146-e149","source":"Crossref","is-referenced-by-count":50,"title":["Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: An update 5 years later"],"prefix":"10.17269","volume":"105","author":[{"given":"Benedikt","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kurdyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,1]]},"reference":[{"issue":"3","key":"105020146_CR1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF03405469","volume":"99","author":"B Fischer","year":"2008","unstructured":"Fischer B, Rehm J, Goldman B, Popova S. Non-medical use of prescription opioids and public health in Canada: An urgent call for research and interventions development. Can J Public Health 2008;99(3):182\u201384.","journal-title":"Can J Public Health"},{"key":"105020146_CR2","doi-asserted-by":"crossref","DOI":"10.18356\/12e89c6c-en-fr-es","volume-title":"Narcotic Drugs Technical Report: Estimated World Requirements for 2013 \u2014 Statistics for 2011","author":"International Narcotics Control Board.","year":"2013","unstructured":"International Narcotics Control Board. Narcotic Drugs Technical Report: Estimated World Requirements for 2013 \u2014 Statistics for 2011. New York, NY: United Nations, 2013."},{"issue":"3","key":"105020146_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/dar.12025","volume":"32","author":"B Fischer","year":"2013","unstructured":"Fischer B, Ialomiteanu A, Boak A, Adlaf E, Rehm J, Mann R. Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada. Drug Alcohol Rev 2013;32(3):276\u201387.","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"105020146_CR4","first-page":"256","volume":"56","author":"B Brands","year":"2010","unstructured":"Brands B, Paglia-Boak A, Sproule BA, Leslie K, Adlaf EM. Nonmedical use of opioid analgesics among Ontario students. Can Fam Physician 2010;56(3):256\u201362.","journal-title":"Can Fam Physician"},{"key":"105020146_CR5","volume-title":"I-Track: Enhanced Surveillance of Risk Behaviours Among People Who Inject Drugs \u2014 Phase I Report","author":"Public Health Agency of Canada.","year":"2006","unstructured":"Public Health Agency of Canada. I-Track: Enhanced Surveillance of Risk Behaviours Among People Who Inject Drugs \u2014 Phase I Report. Ottawa, ON: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2006."},{"issue":"Suppl","key":"105020146_CR6","doi-asserted-by":"crossref","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","volume":"153","author":"B Fischer","year":"2012","unstructured":"Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician 2012;153 (Suppl):ES191\u2013ES203.","journal-title":"Pain Physician"},{"key":"105020146_CR7","volume-title":"Substance Abuse Statistical Tables: Fiscal Year 2007\/2008 to Fiscal Year 2011\/2012","author":"DrugAlcohol Treatment Information System.","year":"2012","unstructured":"Drug and Alcohol Treatment Information System. Substance Abuse Statistical Tables: Fiscal Year 2007\/2008 to Fiscal Year 2011\/2012. Toronto, ON: Centre for Addiction & Mental Health, 2012."},{"key":"105020146_CR8","volume-title":"Office of the Chief Coroner Report for 2009\u20132011","author":"Office of the Chief Coroner of Ontario.","year":"2012","unstructured":"Office of the Chief Coroner of Ontario. Office of the Chief Coroner Report for 2009\u20132011. Toronto: Ministry of Community Safety and Correctional Services, 2012."},{"key":"105020146_CR9","doi-asserted-by":"publisher","first-page":"e60600","DOI":"10.1371\/journal.pone.0060600","volume":"84","author":"P Madadi","year":"2013","unstructured":"Madadi P, Hildebrandt D, Lauwers AE, Koren G. Characteristics of opioid-users whose death was related to opioid-toxicity: A population-based study in Ontario, Canada. PLoS One 2013;(84):e60600.","journal-title":"PLoS One"},{"issue":"2","key":"105020146_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1155\/2013\/651649","volume":"18","author":"KD Shield","year":"2013","unstructured":"Shield KD, Jones W, Rehm J, Fischer B. Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009. Pain Res Manag 2013;18(2):69\u201374.","journal-title":"Pain Res Manag"},{"issue":"1","key":"105020146_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1747-597X-8-7","volume":"8","author":"B Fischer","year":"2013","unstructured":"Fischer B, Ialomiteanu A, Kurdyak P, Mann RE, Rehm J. Reductions in nonmedical prescription opioid use among adults in Ontario, Canada: Are recent policy interventions working? Subst Abuse Treat Prev Policy 2013;8(1):4.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"105020146_CR12","volume-title":"Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings","author":"Substance AbuseMental Health Services Administration.","year":"2011","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011."},{"key":"105020146_CR13","volume-title":"Canadian Alcohol and Drug Use Monitoring Survey (CADUMS): Summary of Results for 2011, 2012","author":"Health Canada.","year":"2012","unstructured":"Health Canada. Canadian Alcohol and Drug Use Monitoring Survey (CADUMS): Summary of Results for 2011, 2012. Available at: http:\/\/www.hc-sc.gc.ca \/hc-ps\/drugs-drogues\/stat\/_2011\/summary-sommaire-eng.php (Accessed November 23, 2012)."},{"key":"105020146_CR14","volume-title":"Policy Impact: Prescription Painkiller Overdoses, 2013","author":"Centers for Disease ControlPrevention.","year":"2013","unstructured":"Centers for Disease Control and Prevention. Policy Impact: Prescription Painkiller Overdoses, 2013. Available at: http:\/\/www.cdc.gov \/homeandrecreationalsafety\/rxbrief\/ (Accessed July 5, 2013)."},{"key":"105020146_CR15","volume-title":"HIV\/AIDS: Reports and Publications, 2013","author":"Health Canada.","year":"2013","unstructured":"Health Canada. HIV\/AIDS: Reports and Publications, 2013. Available at: http:\/\/www.phac-aspc.gc.ca \/aids-sida\/publication\/ (Accessed July 5, 2013)."},{"issue":"12","key":"105020146_CR16","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1111\/j.1360-0443.2010.03092.x","volume":"105","author":"B Fischer","year":"2010","unstructured":"Fischer B, Bibby M, Bouchard M. The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: A review of sourcing routes and control measures. Addiction 2010;105(12):2062\u201370.","journal-title":"Addiction"},{"issue":"4","key":"105020146_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","volume":"74","author":"JS Potter","year":"2013","unstructured":"Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, et al. Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from Starting Treatment With Agonist Replacement Therapies (START). J Stud Alcohol Drugs 2013;74(4):605\u201313.","journal-title":"J Stud Alcohol Drugs"},{"issue":"12","key":"105020146_CR18","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","volume":"68","author":"RD Weiss","year":"2011","unstructured":"Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Arch Gen Psychiatry 2011;68(12):1238\u201346.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"105020146_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","volume":"22","author":"BA Moore","year":"2007","unstructured":"Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O\u2019Connor PG, et al. Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. J Gen Intern Med 2007;22(4):527\u201330.","journal-title":"J Gen Intern Med"},{"key":"105020146_CR20","volume-title":"A Systems Approach to Substance Use in Canada: Recommendations for a National Treatment Strategy","author":"National Treatment Strategy Working Group.","year":"2008","unstructured":"National Treatment Strategy Working Group. A Systems Approach to Substance Use in Canada: Recommendations for a National Treatment Strategy. Ottawa: National Framework for Action to Reduce the Harms Associated with Alcohol and Other Drugs and Substances in Canada, 2008."},{"key":"105020146_CR21","volume-title":"National Treatment Indicators Report: 2010\u20132011 Data","author":"T Pirie","year":"2013","unstructured":"Pirie T, Jesseman R, National Treatment Indicators Working Group. National Treatment Indicators Report: 2010\u20132011 Data. Ottawa: Canadian Centre on Substance Abuse, 2013."},{"issue":"12","key":"105020146_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/pds.2190","volume":"20","author":"B Fischer","year":"2011","unstructured":"Fischer B, Jones W, Krahn M, Rehm J. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005\u20132010. Pharmacoepidemiol Drug Saf 2011;20(12):1269\u201377.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"105020146_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12927\/hcq.2011.22153","volume":"14","author":"T Gomes","year":"2011","unstructured":"Gomes T, Juurlink DN, Moineddin R, Gozdyra P, Dhalla I, Paterson M, et al. Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q 2011;14(1):22\u201324.","journal-title":"Healthc Q"},{"issue":"4","key":"105020146_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/pds.3404","volume":"22","author":"B Fischer","year":"2013","unstructured":"Fischer B, Jones W, Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005\u20132009. Pharmacoepidemiol Drug Saf 2013;22(4):438\u201342.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"105020146_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1503\/cmaj.090784","volume":"181","author":"IA Dhalla","year":"2009","unstructured":"Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181(12):891\u201396.","journal-title":"CMAJ"},{"issue":"3","key":"105020146_CR26","first-page":"e92","volume":"57","author":"IA Dhalla","year":"2011","unstructured":"Dhalla IA, Mamdani MM, Gomes T, Juurlink DN. Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can Fam Physician 2011;57(3):e92\u2013e96.","journal-title":"Can Fam Physician"},{"issue":"8","key":"105020146_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/070674371105600808","volume":"56","author":"E Amari","year":"2011","unstructured":"Amari E, Rehm J, Goldner E, Fischer B. Nonmedical prescription opioid use and mental health and pain comorbidities: A narrative review. Can J Psychiatry 2011;56(8):495\u2013502.","journal-title":"Can J Psychiatry"},{"issue":"9","key":"105020146_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.puhe.2012.04.010","volume":"126","author":"B Fischer","year":"2012","unstructured":"Fischer B, Nakamura N, Urbanoski K, Rush B, Rehm J. Correlations between population levels of prescription opioid use and prescription opioid-related substance use treatment admissions in the USA and Canada since 2001. Public Health 2012;126(9):749\u201351.","journal-title":"Public Health"},{"issue":"6","key":"105020146_CR29","first-page":"E671","volume":"16","author":"A Lusted","year":"2013","unstructured":"Lusted A, Roerecke M, Goldner E, Rehm F, Fischer B. Prevalence of pain among non-medical prescription opioid users in substance use treatment populations: Systematic review and meta-analysis. Pain Physician 2013;16(6):E671\u2013E684.","journal-title":"Pain Physician"},{"issue":"9","key":"105020146_CR30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3109\/10826084.2011.552932","volume":"46","author":"Roy","year":"2011","unstructured":"Roy \u00c9, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: New challenges for harm reduction. Subst Use Misuse 2011;46(9):1142\u201350.","journal-title":"Subst Use Misuse"},{"issue":"7","key":"105020146_CR31","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","volume":"107","author":"J Bruneau","year":"2012","unstructured":"Bruneau J, Roy E, Arruda N, Zang G, Jutras-Aswad D. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction 2012;107(7):1318\u201327.","journal-title":"Addiction"},{"key":"105020146_CR32","volume-title":"The Way Forward: Stewardship for Prescription Narcotics in Ontario","author":"Expert Working Group on Narcotic Addiction.","year":"2012","unstructured":"Expert Working Group on Narcotic Addiction. The Way Forward: Stewardship for Prescription Narcotics in Ontario. Toronto: Ontario Ministry of Health and Long-Term Care, 2012."},{"key":"105020146_CR33","volume-title":"Statement on the Authorization of Generic OxyContin, 2012","author":"Health Canada.","year":"2013","unstructured":"Health Canada. Statement on the Authorization of Generic OxyContin, 2012. Available at: http:\/\/www.hc-sc.gc.ca \/ahc-asc\/media\/ftr-ati\/_2012\/2012_1 76-eng.php (Accessed July 5, 2013)."},{"key":"105020146_CR34","volume-title":"Release of First Do No Harm: Responding to Canada\u2019s Prescription Drug Crisis Collective Challenge Requires Collective Action, 2013","author":"Canadian Centre on Substance Abuse.","year":"2013","unstructured":"Canadian Centre on Substance Abuse. Release of First Do No Harm: Responding to Canada\u2019s Prescription Drug Crisis Collective Challenge Requires Collective Action, 2013. Available at: http:\/\/www.ccsa.ca \/2013%20CCSA%20Documents\/CCSA-Prescription-Drug-Strategy-news-release-2013-en.pdf (Accessed July 5, 2013)."},{"key":"105020146_CR35","volume-title":"Federal Tobacco Control Strategy (FTCS), 2007","author":"Health Canada.","year":"2013","unstructured":"Health Canada. Federal Tobacco Control Strategy (FTCS), 2007. Available at: http:\/\/www.hc-sc.gc.ca \/hc-ps\/tobac-tabac\/res\/news-nouvelles\/ftcs-sflt-eng.php (Accessed July 5, 2013)."},{"key":"105020146_CR36","volume-title":"National Anti-Drug Strategy for Safer and Healthier Communities, 2008","author":"Department of Justice Canada.","year":"2013","unstructured":"Department of Justice Canada. National Anti-Drug Strategy for Safer and Healthier Communities, 2008. Available at: http:\/\/www.nationalantidrugstrategy.gc.ca \/ (Accessed July 5, 2013)."},{"issue":"6","key":"105020146_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.15288\/jsad.2007.68.886","volume":"68","author":"J Rehm","year":"2007","unstructured":"Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, et al. The cost of alcohol, illegal drugs, and tobacco in Canada in 2002. J Stud Alcohol Drugs 2007;68(6):886\u201395.","journal-title":"J Stud Alcohol Drugs"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.17269\/cjph.105.4143\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.17269\/cjph.105.4143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.17269\/cjph.105.4143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T05:54:25Z","timestamp":1718862865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.17269\/cjph.105.4143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["105020146"],"URL":"https:\/\/doi.org\/10.17269\/cjph.105.4143","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}